Denmark urges EU to tighten Russian visa restrictions after alleged assassination plot
Denmark has urged European Union countries to introduce tougher travel restrictions on Russian nationals following allegations that Moscow's in...
Johnson & Johnson (J&J) is facing its first lawsuits in the United Kingdom over claims that its talc-based products cause cancer, as it continues to battle tens of thousands of similar cases in the United States.
The case was filed at the English High Court on Tuesday against J&J and Kenvue UK Limited, a subsidiary of Kenvue, J&J’s former consumer health division, which was spun off in 2023.
Law firm KP Law said it had brought the claim on behalf of more than 3,000 people who allege they developed ovarian cancer, mesothelioma, or other illnesses after using J&J’s baby powder between 1965 and 2023.
The firm argues that J&J’s talc products contained carcinogenic fibres, including asbestos, which has been linked to mesothelioma. J&J has consistently denied these allegations, insisting its talc products are safe and asbestos-free.
J&J referred all queries to Kenvue, stating that the latter “retained responsibility and any potential liability for talc-related litigation outside the United States and Canada.” Kenvue, for its part, maintained that J&J’s baby powder “did not contain asbestos and does not cause cancer.”
The company is already facing tens of thousands of lawsuits in the U.S., where claimants say they developed cancer after using J&J’s talc-based products. J&J halted sales of its talc baby powder in the U.S. in 2020, replacing it with a cornstarch-based alternative, and did the same in the U.K. in 2023.
Its attempts to resolve the lawsuits through bankruptcy have been rejected three times by U.S. federal courts. Last week, J&J was ordered to pay $966 million to the family of a woman who died from mesothelioma, one of the largest awards against the company, though it may be reduced on appeal.
While U.S. courts can issue large punitive damages, English courts generally limit compensation to actual losses suffered, with exemplary damages only awarded in rare cases of deliberate wrongdoing.
KP Law valued the collective claim at around £1 billion ($1.34 billion). Unlike in the U.S., the case will be decided by a judge rather than a jury. Kenvue said it believes the judge will conclude that its talc-based baby powder does not cause cancer.
European leaders backing Ukraine met in Berlin on Thursday 19 November and warned that no peace deal should be settled without them.
Three people have been killed and around 15 injured after Russian ballistic missiles struck three bridges over the Dnipro River in Kyiv, according to the Ukrainian capital’s mayor, Vitali Klitschko.
Azerbaijani President Ilham Aliyev met Vietnamese Prime Minister Le Minh Hung in Hanoi on 20 November, during a visit highlighting the longstanding friendship and growing strategic partnership between the two countries.
Britain and the European Union have reached an agreement to ease trade, expand opportunities for young people and deepen economic ties, in a major step towards rebuilding relations after Brexit.
Georgia has declared 22 November 2026 a national day of mourning following a deadly residential building collapse in the Kvemo Ponichala district of Tbilisi.
For the first time in more than a quarter of a century, the United States can no longer say it has eliminated measles as health experts warn the American outbreak reflects a collapse in trust in vaccines.
A new study in mice suggests the brain’s protective barrier does more than block harmful substances. It also delivers essential proteins from the body, a process that may break down early in Alzheimer’s disease and offer a new target for treatment.
Here's your AnewZ Daily Brief for the 5th of November, as health emergencies, humanitarian crises, political shifts, and cybersecurity threats put governments and essential services under pressure across the globe. Here are five stories worth your attention.
Kazakhstan plans to manufacture 494 types of medicines through eight major investment projects worth a combined $862 million, Health Minister Akmaral Alnazarova announced on 3 November, local media reported.
Dengue fever has killed more people in Bangladesh this year than in the whole of 2025, with October the deadliest month so far, data from Bangladesh's Health Ministry shows.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment